Evidence Basis
This local Codex synthesis uses the generated Orphanet structured record for ORPHA:56 and the PubMed caches integrated into the YAML. Falcon and OpenAI live provider attempts both timed out without artifacts, so the curated YAML is based on local review of the deterministic evidence caches listed below.
Core Disease Mechanism
- Alkaptonuria maps directly to MONDO:0008753 and ORPHA:56.
- Orphanet lists HGD as the disease-causing gene and records autosomal recessive inheritance.
- HGD encodes homogentisate 1,2-dioxygenase, which normally converts homogentisic acid to maleylacetoacetic acid in tyrosine degradation.
- Biallelic HGD pathogenic variants reduce this enzyme activity, causing accumulation of homogentisic acid in urine, body fluids, and tissues.
- Oxidation of homogentisic acid generates benzoquinone-derived products that form melanin-like polymers and bind connective tissue components.
- Ochronotic pigment deposition in collagen-rich tissues, especially cartilage, explains the characteristic ochronosis, cartilage and disk calcification, and progressive spine and large-joint osteoarthropathy.
Clinical Interpretation
- Urinary homogentisic acid elevation is the highest-confidence biochemical phenotype and supports diagnosis.
- Dark urine can appear early because homogentisic acid oxidizes on standing, whereas ochronosis and arthritis usually become prominent in adulthood.
- The phenotype is multisystemic in later disease, with recognized cardiac valve calcification, renal or prostatic stones, and tendon or ligament involvement.
- HGD variant classes are heterogeneous. Published cohorts support HGD as the causal gene but show limited genotype-to-clinical-phenotype prediction.
Treatment-Relevant Mechanism
- Nitisinone acts upstream of HGA formation in tyrosine degradation and reduces urinary HGA. SONIA 2 showed a 99.7 percent reduction in urinary HGA at 12 months and slower clinical progression by cAKUSSI over 48 months.
- This treatment targets HGA accumulation and downstream ochronosis, but it does not restore HGD enzymatic function; the YAML therefore models it as inhibiting the HGA accumulation node rather than correcting the genetic defect.
YAML Integration Notes
- The pathophysiology chain is intentionally compact: HGD molecular-function deficiency, HGA accumulation and oxidation, and ochronotic connective-tissue degeneration.
- Phenotypes are anchored primarily to Orphanet frequency annotations and reinforced with GeneReviews or recent review evidence where available.
- Genetics are represented as biallelic HGD pathogenic variants with cautious genotype-phenotype interpretation.